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Marine macroalgae, or seaweeds, are a formidable source of natural compounds with
diverse biological activities. In the last five decades it has been estimated that more than
3000 natural compounds were discovered from these organisms. The great majority of the
published works have focused on terpenoids. In comparison, glycolipids are a neglected
class of macroalgal secondary metabolites therefore remaining as a largely unknown
reservoir of molecular diversity. Nevertheless, the interest regarding these compounds
has been growing fast in the last decades as activities of ecological or pharmaceutical
interest have been highlighted. This paper will review recent work regarding isolation and
structural characterization of glycolipids from seaweeds and their prospective biological
activities.
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INTRODUCTION
For the last five decades, both chemists and biologists have carried
out an intense effort regarding marine natural products (Bhakuni
and Rawat, 2005; Blunt et al., 2014). Such dedication has resulted
in the discovery of more than 20,000 compounds from marine
microorganisms, invertebrates, and macroalgae (Hu et al., 2011).
Marine organisms appear then as a formidable source of natu-
ral products. While products of primary metabolism like amino
acids, carbohydrates and proteins, are vital for maintaining life
processes, others such as alkaloids, phenolics, steroids, terpenoids,
are secondary metabolites that have ecological, toxicological,
and pharmacological significance (Maschek and Baker, 2008).
Bioactivities such as antiherbivory, antifoulant, antifungal, anti-
tumor, antimicrobial, and antiparasitic effects have been high-
lighted for marine natural products (Noda et al., 1990; Deal et al.,
2003; Bhadury and Wright, 2004; Cheung et al., 2014).
With an estimation of more than 30,000 species identified
around the world, marine macroalgae, or seaweeds, constitute a
huge source of natural compounds with diverse biological activ-
ities (Guiry, 2012). In the last 50 years it has been estimated
that more than 3000 natural compounds were discovered from
these organisms (Leal et al., 2013). The great majority of the pub-
lished works have focused on terpenoids, phenolic compounds,
or polysaccharides. Glycolipids represent a less studied class of
metabolites with recently growing interest. Seaweeds biosyn-
thesize three major types of glycolipids: monogalactosyldiacyl-
glycerides (MGDGs), digalactosyldiacylglycerides (DGDGs), and
sulfoquinovosyldiacylglycerides (SQDGs) (Figure 1).
These glycoglycerolipids are present in chloroplasts of eukary-
otic algae where MGDGs and DGDGs are the most abundant
lipids of the thylakoid membrane and appear to play a crucial role
in photosynthesis (Hölzl and Dörmann, 2007).
This work will present a concise review of studies from the last
15 years regarding the isolation and structural characterization of
bioactive glycolipids from marine macroalgae.
OCHROPHYTA
The MGDG isolated from Petalonia binghamiae was character-
ized as a potent inhibitor of the activities of mammalian DNA
polymerase α (Mizushina et al., 2001).
SQDG and DGDG from the Japanese macroalga Sargassum
horneri were found to induce apoptosis of the human colon carci-
noma Caco-2 cell when associate with sodium butyrate (Hossain
et al., 2005).
The acetone fraction of Sargassum thunbergii extract
exhibited moderate antifungal effects on Candida albicans.
Further investigation of this extract led to the isolation of four
MGDGs, two of them newly described as (2S)-1-O-(5Z,8Z,
11Z,14Z,17Z-eicosapentaenoyl)-2-O-(9Z,12Z,15Z-octadecatrien
oyl)-3-O-β-D-galactopyranosyl- sn-glycerol and (2S) -1-O-
(9Z,12Z, 15Z-octadecatrienoyl)-2-O-(6Z,9Z,12Z,15Z-octad
ecatetraenoyl)-3-O- β -D-galactopyranosyl-sn-glycerol (Kim
et al., 2007).
Two glucopyranosyldiacylglycerols were isolated from
Sargassum fulvellum. The two compounds were identified to be
1-O-palmitoyl-2-O-oleoyl-3-O-(α-D-glucopyranosyl)-glycerol
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FIGURE 1 | General structure of the three main glycoglycerolipids from seaweeds. R, acyl chain.
and 1-O-myristoyl-2-O-oleoyl-3-O-(α–glucopyranosyl)-glycerol
and showed fibrinolytic activity in the reaction system of single
chain urokinase-type plasminogen activator and plasminogen
(Wu et al., 2009).
The dichloromethane-methanol (7/3) extract of Lobophora
variegata from the Yucatan coast (Mexico) demonstrated activity
against the protozoa Trichomonas vaginalis, with an IC50 value
of 3.2μg/ml (Cantillo-Ciau et al., 2010). Further fractionation
of that extract was undergone and led to a chloroform fraction
that showed activity against the protozoa T. vaginalis, Giardia
intestinalis, and Entamoeba histolytica, with good selectivity
(SI > 10). Purification of this fraction allowed the isolation
of three SQDGs: the major compound 1-O-palmitoyl-2-
O-myristoyl-3-O-(6-sulfo-α-D-quinovopyranosyl)-glycerol,
along with small amounts of 1,2-di-O-palmitoyl-3-O-(6-
sulfo-α-D-quinovopyranosyl)-glycerol and a new compound
identified as 1-O-palmitoyl-2-O-oleoyl-3-O-(6-sulfo-α-D-
quinovopyranosyl)-glycerol.
Plouguerné et al. (2010) isolated MGDGs in a fraction
obtained from Sargassum muticum collected from the coast of
Britanny (France), that inhibited the bacteria Shewanella putre-
faciens and Polaribacter irgensii and the fungi Halosphaeriopsis
mediosetigera, Asteromyces cruciatus, Lulworthia uniseptata,
Monodictys pelagica, all involved in marine microfouling.
The inhibitory activity was reported for a concentration
of 0.75mg/l.
The crude ethyl acetate extract of Fucus evanescens, col-
lected on the Arctic coast of Ungava Bay, Nunavik (Canada),
showed strong antibacterial activity (≥4 log10 colony-forming
units (cfu) againstHemophilus influenza, Legionella pneumophila,
Propionibacterium acnes, and Streptococcus pyogenes, when tested
at 100μg/ml. This glycolipid rich extract also inhibited by 3
log10 cfu the bacteria Clostridium difficile and Staphylococcus
aureus (Amiguet et al., 2011). Further purification of the gly-
colipid rich extract led to the isolation and identification of the
main compound as the MGDG 2′, 3′-propyl dilinolenate-β-D-
galactopyranoside.
El Baz et al. (2013) investigated the structures and biologi-
cal activities of sulfolipids from the Mediterranean macroalgae
Dilophus fasciola and Taonia atomaria. The authors highlighted
antibacterial and antiviral activities from sulfolipids extracts. The
major compounds were identified as SQDG and SQMG (sulfo-
quinovosylmonoacylglyceride).
SGDGs were identified in fractions obtained after the
purification of the organic extract of the Brazilian macroalga
Sargassum vulgare. The main SQDG responsible for the anti-
HSV1 and anti-HSV2 activities highlighted was characterize as 1,
2-di-O-palmitoyl-3-O-(6-sulfo-α-D-quinovopyranosyl)-glycerol
(Plouguerné et al., 2013). The structure of the SQDG was
determined using Electrospray Ionization Mass Spectrometry
(ESI-MS) (Figure 2A) and the configuration of the anomeric car-
bon was confirmed by 1H and 13C Nuclear Magnetic Resonance
(NMR) analysis, based on Heteronuclear Single Quantum
Coherence (HSQC) fingerprints (Figure 2B).
Imbs et al. (2013) isolated a highly unsaturated monogalac-
tosyldiacylglycerol (MGDG) from the ethanol extract of Fucus
evanescens, collected from the west coast of the Iturup Island
of the Sea of Okhotsk (Russia). This compound, identified
as 1-O-(5Z,8Z,11Z,14Z,17Z-eicosapentanoyl)-2-O-(6Z,9Z,12Z,
15Z-octadecatetraenoyl)-3-O-β-D-galactopyranosyl-sn-glycerol,
inhibited the growth of human melanoma cells with an IC50 =
104μM.
RHODOPHYTA
Ohta et al. (1998) isolated the SQDG KM043 from Gigartina
tenella, collected at Sagami Bay, Kanagawa, Japan, that demon-
strated inhibition of DNA polymerase α, DNA polymerase β and
HIV-reverse transcriptase type 1, with respective IC50 values of
0.25, 3.6, and 11.2μM. The structure of the SQDG was identified
as 1-(1′-O- α-D-sulfoquinovosyl)-2-palmitoyl-3-[5′′ (E), 8′′ (E),
11′′ (E), 14′′ (E), 17′′ (E)-eicosapentaenyl]-syn-glycerol.
Al-Fadhli et al. (2006) isolated three distinct fractions con-
taining polar glycolipids from the soluble fraction of crude
methanolic extract of Chondria armata. The structure of the gly-
colipids was elucidated using multidimensional NMR techniques
and ESI-MS in the positive ion mode. The most active fraction
showed significant growth inhibition of the bacteria Klebsiella
sp., the yeast Candida albicans and the fungus Cryptococcus
neoformans when tested at the concentration of 130μg/disc. The
main compound present in the fraction was identified as the
MGDG 1-eicosapentanoyl-2-palmitoyl-3-O-galactopyranosyl-
glycerol.
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FIGURE 2 | Electrospray ionization mass spectrum (ESI-MS) of main
SQDG from Sargassum vulgare (negative mode). The fragmentation
pathway of the ion at m/z = 794 is compatible with the structure of
1,2-di-O-palmitoyl-3-O-(6-sulfoquinovopyranosyl)-glycerol (A). The
configuration of the anomeric carbon was confirmed analyzing the
partial fingerprint spectrum 2D-1H/13C-HSQC of the polar head group of
SQDG (B). Gly, glycerol; Qui, quinovose. (Adapted from Plouguerné
et al., 2013).
The MGDG lithonoside isolated from the cytotoxic hexane-
soluble extract of the Fijian coralline macroalga Hydrolithon rein-
boldii demonstrated moderate growth inhibitory activity against
cancer cell lines with a mean IC50 value of 19.8μM (Jiang et al.,
2008).
de Souza et al. (2012) isolated an anti-HSV (herpes simplex
virus) glycolipid-enriched fraction from the Brazilian macroalga
Osmundaria obtusiloba. The major compound of the active
fraction was identified as the SQDG 1,2-di-O-acyl-3-O-(6-deoxy-
6-sulfo-α-D-glucopyranosyl)-sn-glycerol.
Tsai and Pan (2012) isolated SQDGs from Porphyra crispata
collected from northeastern Taiwan that inhibited the growth of
human hepatocellular carcinoma cell line (HepG2), with an IC50
of 126μg/ml.
El Baz et al. (2013) investigated the structures and bio-
logical activities of sulfolipids from Laurencia papillosa and
Galaxaura cylindrica collected from the Red Sea. The authors
highlighted antibacterial and antiviral activities from sulfolipids
extracts. The major compounds were identified as SQDG and
SQMG.
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Anti-inflammatory activity was highlighted for two
SQDGs isolated from Palmaria palmata (Banskota et al.,




demonstrated nitric oxide inhibitory activity with IC50 values of
36.5 and 11.0μM, respectively.
CHLOROPHYTA
Wang et al. (2007) isolated a SQDG from the n-butanol frac-
tion of the invasive Caulerpa racemosa collected from the South
China Sea. The SQDG compound was characterized using spec-
troscopic methods as (2S)-1,2-di-O-palmitoyl-3-O-(6′-sulfo-α-
D-quinovopyranosyl) glycerol, and was active against HSV-2,
with a 50% inhibitory concentration (IC50) of 15.6mg ml−1
against both standard and clinical strains of HSV-2.
MGDGs capsofulvesin A and B, along with the MGMG
capsofulvesin C, isolated from Capsosiphon fulvescens collected
from the southern coastal area of Wando (Korea), demonstrated
cholinesterase inhibitory activity (Fang et al., 2012).
Islam et al. (2014) revealed for the first time the aldose
reductase inhibitory activity of the capsofulvesin A and
capsofulvesin B.
Such results highlighted the potential health benefits of C. ful-
vescens in improving neurotransmission as well as in preventing
diabetic complications.
El Baz et al. (2013) investigated the structures and biological
activities of sulfolipids from the Mediterranean macroalga Ulva
fasciata. The authors highlighted antibacterial and antiviral activ-
ities from sulfolipids extracts, and the major compounds were
identified as SQDG and SQMG.
CONCLUSION
Among the three phyla of marine macroalgae, Ochrophyta
appears as the main source of recently reported bioactive gly-
colipids, followed by Rhodophyta and Chlorophyta. Within
Ochrophyta, the order Fucales was the most reported, followed
by Dictyotales.
Among bioactive glycolipids isolated frommarine macroalgae,
SQDGs, and MGDGs dominated the reports for the last 15 years.
Khotimchenko (2003) studied the distribution of glyceroglycol-
ipids in marine macroalgae and highlighted the predominance
of SQDG as a characteristic of brown seaweeds from the order
Fucales. It would then be logical to expect such order as a major
source of bioactive SQDGs. However, according to the recent
literature, bioactive SQDGs were more abundant in Dictyotales.
The most reported biological activities for glycolipids from
seaweeds were antibacterial, antitumor, and antiviral activities,
enhancing the pharmacological potential of these compounds.
Less reported, but of significant interest, is the ecological role that
may assume glycolipids biosynthetized by seaweeds. Antifouling,
and antiherbivory activities were already reported for glycolipids
from Sargassummuticum and Fucus vesiculosus, respectively (Deal
et al., 2003; Plouguerné et al., 2010).
Concerning the mechanism of action of glycolipids, it remains
until today relatively obscure. Recent studies about synthesis
and structural modification of glycoglycerolipids helped to
understand the structure-activity relationship. On general point
of view, the bioactivities of glycoglycerolipids are related to the
sugar moiety, the position of the glycerol linkage to the sugar, the
length and location of the acyl chain, and the anomeric configura-
tion of the sugar (Zhang et al., 2014). Polyunsaturated fatty acids
(PUFAs) are biologically active compounds, which are abundant
components of macrophytic glycolipids (Khotimchenko, 1993a,b,
2003; Sanina et al., 2000, 2004; Raposo et al., 2013). Therefore, it
has been hypothesize that fatty acids may be responsible for bio-
logical activities highlighted from macrophytic glycolipids (Tsai
and Pan, 2012). As the distribution of PUFAs in glycolipids from
seaweeds depends from their taxonomic position, it may then
be logical to expect some taxa to be more active than others
(Sanina et al., 2004). Among glycolipids, the degree of saturation
of fatty acid increased in the lines of MGDG->DGDG->SQDG.
Concerning SQDGs, the antiviral activity may be related to the
presence of the sulfonate group (Plouguerné et al., 2013). The sul-
fate moiety along with the nature of the fatty acids of the SQDGs
are also important for the inhibition of DNA polymerase α and β
(Mizushina et al., 1996, 1997; Hanashima et al., 2000, 2001).
Glycoglycerolipids from seaweeds are compounds with both
biotechnological potential and ecological interest. Further stud-
ies are needed to extend knowledge concerning the mechanism
of action of these molecules as well as their distribution between
macroalgal species.
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